55.7

Kazuhiro Kasai

Iwate Medical University

Kazuhiro Kasai's research has made significant contributions to the treatment and management of hepatocellular carcinoma (HCC), particularly in the context of advanced disease. Studies have explored various chemotherapy regimens, including hepatic arterial infusion therapy, which has shown promise for patients with major portal vein tumor thrombus. Additionally, investigations into the mechanisms underlying efficacy have implicated transforming growth factor regulation. Furthermore, research on liver stiffness patterns has identified bimodal peaks indicative of drug-induced liver injury. Kasai's work also highlights the therapeutic potential of combination therapies involving intra-arterial 5-fluorouracil and systemic pegylated interferon α‐2b for HCC with portal venous invasion, as well as the benefits of branched-chain amino acid-enriched nutrition post-radiofrequency ablation.

Hepatocellular Carcinoma
Commercial signal 55.3
Scientific signal 57.5
Social signal 57.4
Papers 7
1 Patent-to-paper cites
91 Paper cites

scientifiq.ai is an experimental platform. The platform relies on open source data and it may contain errors. Its primary goal is to advance scientific research on innovation.